Products for Research Use Only

SARS-CoV-1 Pseudovirus

CAT: 0223-95-204Size: 1.0 mL (0.5 mL x 2 Vials)Dry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0223-95-204Size:1.0 mL (0.5 mL x 2 Vials)
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Background
SARS-CoV-1 Pseudovirus uses HIV pseudotyped with SARS-CoV-1 spike protein and firefly luciferase reporter. This pseudovirus effectively infects human ACE2 overexpressing cells and can be used to screen for inhibitors of Spike-ACE2 interaction, determine neutralizing antibody titers, and is a valuable tool for COVID-19 vaccine development as well.
NCBI Gene ID
43740568
Swiss Prot
P0DTC1
Accession Number
QHD43416
Type
Pseudovirus
Source
HEK293 cells
Field of Research
Infectious Disease, COVID-19
Buffer
DMEM/10% FBS
Shipping Conditions
Dry Ice
Storage Conditions
The pseudovirus is stable in a liquid state at -70˚ for 12 months. Avoid repeated freeze-thaw cycles.
Applications Notes
Click here to download6
NCBI Official Name
Surface glycoprotein
NCBI Organism
Severe acute respiratory syndrome coronavirus 2
Other Product Names
Spike glycoprotein Receptor-binding domain, S glycoprotein, Spike protein, Delta variant spike, Delta variant pseudovirus, Delta, pseudovirus reporter, reporter virus particle
Tested Applications
Neutralization assay, Viral Infection
Species
SARS-CoV-1 (COVID-19) Spike pseudovirus
Protein ID
1791269090
Physical Properties
Liquid